Biosmart Coltd Stock Shares Owned By Institutions
038460 Stock | KRW 4,985 480.00 10.65% |
BioSmart CoLtd fundamentals help investors to digest information that contributes to BioSmart CoLtd's financial success or failures. It also enables traders to predict the movement of BioSmart Stock. The fundamental analysis module provides a way to measure BioSmart CoLtd's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioSmart CoLtd stock.
BioSmart |
BioSmart CoLtd Company Shares Owned By Institutions Analysis
BioSmart CoLtd's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current BioSmart CoLtd Shares Owned By Institutions | 1.07 % |
Most of BioSmart CoLtd's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioSmart CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Competition |
Based on the latest financial disclosure, 1.07% of BioSmart CoLtd are shares owned by institutions. This is much higher than that of the Technology Hardware, Storage & Peripherals sector and significantly higher than that of the Information Technology industry. The shares owned by institutions for all Republic of Korea stocks is notably lower than that of the firm.
BioSmart Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioSmart CoLtd's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioSmart CoLtd could also be used in its relative valuation, which is a method of valuing BioSmart CoLtd by comparing valuation metrics of similar companies.BioSmart CoLtd is currently under evaluation in shares owned by institutions category among related companies.
BioSmart Fundamentals
Return On Equity | 2.28 | |||
Return On Asset | 0.0086 | |||
Profit Margin | (0.03) % | |||
Operating Margin | 0.01 % | |||
Current Valuation | 153.4 B | |||
Shares Outstanding | 19.98 M | |||
Shares Owned By Insiders | 23.20 % | |||
Shares Owned By Institutions | 1.07 % | |||
Price To Earning | 79.80 X | |||
Price To Sales | 0.33 X | |||
Revenue | 189.18 B | |||
Gross Profit | 58.91 B | |||
EBITDA | 8.09 B | |||
Net Income | 633.79 M | |||
Cash And Equivalents | 433.16 M | |||
Cash Per Share | 966.69 X | |||
Total Debt | 33.07 B | |||
Debt To Equity | 0.42 % | |||
Current Ratio | 1.50 X | |||
Cash Flow From Operations | 2.33 B | |||
Number Of Employees | 164 | |||
Beta | 1.02 | |||
Market Capitalization | 73.22 B | |||
Total Asset | 225.85 B | |||
Retained Earnings | 8.06 B | |||
Working Capital | 6.46 B | |||
Current Asset | 22.12 B | |||
Current Liabilities | 15.66 B | |||
Z Score | 1.2 | |||
Annual Yield | 0.02 % | |||
Net Asset | 225.85 B |
About BioSmart CoLtd Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioSmart CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioSmart CoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioSmart CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioSmart CoLtd in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioSmart CoLtd's short interest history, or implied volatility extrapolated from BioSmart CoLtd options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioSmart CoLtd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the BioSmart CoLtd information on this page should be used as a complementary analysis to other BioSmart CoLtd's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for BioSmart Stock analysis
When running BioSmart CoLtd's price analysis, check to measure BioSmart CoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioSmart CoLtd is operating at the current time. Most of BioSmart CoLtd's value examination focuses on studying past and present price action to predict the probability of BioSmart CoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioSmart CoLtd's price. Additionally, you may evaluate how the addition of BioSmart CoLtd to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Bonds Directory Find actively traded corporate debentures issued by US companies |